Trends in survival of patients with Burkitt lymphoma/leukemia in the USA: an analysis of 3691 cases-Reference-Cited by-同舟云学术

Trends in survival of patients with Burkitt lymphoma/leukemia in the USA: an analysis of 3691 cases

Published:2013-06-13 Issue:24 Volume:121 Page:4861-4866
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Costa Luciano J.¹,Xavier Ana C.²,Wahlquist Amy E.³,Hill Elizabeth G.³

Affiliation:

1. Division of Hematology and Oncology, Department of Medicine, Medical University of South Carolina, Charleston, SC;

2. Division of Hematology and Oncology, Department of Pediatrics, Medical University of South Carolina, Charleston, SC; and

3. Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC

Abstract

Key Points Survival of patients with BL improved substantially in the United States during the past decade, mainly among young adults. Survival of patients with BL remains relatively low, particularly for older and black patients, identifying an unmet need.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/121/24/4861/1366362/4861.pdf

Reference25 articles.

1. A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial).;Mead;Blood,2008

2. Hyper-CVAD program in Burkitt’s-type adult acute lymphoblastic leukemia.;Thomas;J Clin Oncol,1999

3. Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen.;Magrath;J Clin Oncol,1996

4. The Société Française d’Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia.;Patte;Blood,2001

5. Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin’s lymphoma: results of the FAB/LMB 96 international study.;Gerrard;Br J Haematol,2008

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EBV-miR-BART5-3p dysregulates the cell cycle induced proliferation of Burkitt Lymphoma cells through downregulating TP53 (Preprint);2024-04-14

2. Diagnosis and Treatment of Burkitt Lymphoma in Adults: Clinical Practice Guidelines from ERN-EuroBloodNet "Recommendations Carried Out within the Framework of European Reference Network on Rare Haematological Diseases (ERN-EuroBloodNet)-Project ID No 10108571. ERN-EuroBloodNet is Partly Co-Funded by the European Union within the Framework of the Fourth EU Health Programme";2024

3. R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial;The Lancet Haematology;2023-12

4. Clinical Outcomes and Health Care Utilization in Patients With Burkitt Lymphoma;JCO Oncology Practice;2023-09

5. Long-term outcomes in patients with Burkitt lymphoma older than 65 years: an analysis of the Texas Cancer Registry;Annals of Hematology;2023-07-08